Navigation Links
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
Date:12/11/2012

ATLANTA, Dec. 11, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced follow-up findings from an ongoing, open-label, Phase 2, single-agent study suggesting that in patients with relapsed or refractory mantle cell lymphoma (MCL), both those who were bortezomib-naive and bortezomib-exposed, the investigational oral agent ibrutinib (PCI-32765) resulted in high and durable responses and was generally well tolerated. In the study, 111 patients received ibrutinib and 110 were evaluable for efficacy. The median follow-up time was 9.2 months, with a range of time to response to treatment of 1.4 to 16.4 months.

The results were presented by lead investigator Michael L. Wang, M.D., associate professor in the Department of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center, at the 54th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Ga. The study showed an overall response rate (ORR) of 68 percent, including a complete response (CR) of 22 percent and a partial response (PR) of 46 percent with a median progression free survival (PFS) estimated at 13.9 months. Results were similar between the bortezomib-naive and bortezomib-exposed patients.

Long-term follow up of the initial 51 patients enrolled in this study that were presented last year at ASH shows there was an incremental improvement in the response rate over time. The ORR increased for this patient subset from 69 percent in 2011 to an ORR of 75 percent in 2012, with the CR increasing from 16 percent to 39 percent over the same period.

"Now with a larger number of patients studied, we see the overall response rate remains durable and the safety profile continues to appear manageable," said Dr. Wang. "In addition, what is particularly encouraging is that with longer follow-up there is an incremental increase in the number of patients who achiev
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
6. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
7. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
8. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
9. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
10. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... April 24, 2015 In today,s ever-changing ... groups around the world to access diverse skill ... While there are many areas to misstep in ... which best practices are necessary and beneficial in ... According to research by benchmarking firm, Best ...
(Date:4/24/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is scheduled ... Healthcare Conference on May 6 in Boston ... and chief financial officer, and Susie Lisa , vice ... answer session regarding the company with the host analyst at ... the presentation and question and answer session will be available ...
(Date:4/24/2015)... , April 24, 2015 ... portfolio of automated, indication-specific planning tools for radiosurgery/SBRT ... focused software applications aimed at enhancing the workflow ... and spine introduced in 2013 - comes full ... (SRS) planning tools. These new Elements enable on-the-fly ...
Breaking Medicine Technology:Work Around the Clock: Building Effective Global Capabilities 2Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2
... March 1, 2011 Developed by inventor John Vito and represented ... in this lot disclose an advanced medical inhaler design that is ... (Logo:   http://photos.prnewswire.com/prnh/20100614/CG20517LOGO ) The patents will ... IP Auction on March 31, 2011 in New York City. ...
... may not be enough to impact the productivity of ... and coronary artery disease.  That key finding and others ... Alere Health and other industry experts at the Integrated ... (NBCH) Conference in San Francisco, Tuesday, March 1. ...
Cached Medicine Technology:An Easier Way to Breathe Better - ICAP Ocean Tomo Announces an Advanced Medical Inhaler Design 2Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference 2Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference 3
(Date:4/27/2015)... Texas (PRWEB) April 27, 2015 ... Review, H1 2015” provides comparative analysis on ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report on H1 ... 26 market data tables and 14 figures, ...
(Date:4/27/2015)... 2015 The Radiology Business Management ... with applied business information and intelligence, is proud to ... email newsletter for its more than 2,000 members. , ... legislative news sources in that it is exclusively devoted ... of radiology. The newsletter is produced in cooperation with ...
(Date:4/27/2015)... Final Cut Pro X users can ... Pixel Film Studios. A telestrator is a device that allows ... or still video image. Telestrators are often used in sports ... incoming weather patterns. , After users are done drawing,users can ... slider to control the speed of the animation. This can ...
(Date:4/27/2015)... April 27, 2015 PREVENT Life Safety, ... its Texas operations with the addition of an account ... safety services to a growing customer base, Curtis Rice, ... a new Senior Account Manager. Curtis has been added ... existing customers throughout the Houston area and beyond. ...
(Date:4/27/2015)... Hills, California (PRWEB) April 27, 2015 ... and former Amazon engineer, ZendyBeauty offered consumers a ... cosmetic providers at affordable prices. Using a patent-pending ... appointments for standard procedures like Botox®, laser hair ... doctors and their staff had gaps in their ...
Breaking Medicine News(10 mins):Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:ZendyBeauty Is Pleased to Announce the Expansion and Rebranding of the Company as ZendyHealth.com 2
... SAN FRANCISCO, Jan. 6 The American Asthma Foundation,announced ... dust mites are a major source of airborne allergens ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090106/AQTU532 ) , ... Foundation, explains,that "although dust mites are known to trigger ...
... (OTC Bulletin Board: SCIE), a San Diego based ... been awarded U.S. Patent number 7,469,160 for its ... Hitchin, SpectraScience,s CEO, commented, "This patent is another ... The invention provides methods of focusing an instrument ...
... Combines Retinoid and Benzoyl Peroxide in a Single ... Texas, Jan. 6 Galderma Laboratories, L.P. today ... peroxide) Gel 0.1% / 2.5%, the first and ... well-tolerated retinoid adapalene, and benzoyl peroxide, a well-known ...
... ABBOTT PARK, Ill., Jan. 6 Isis Pharmaceuticals, Inc. (Nasdaq: ... ) announced today that Abbott has completed its purchase of ... price of $175 million. In addition to the closing ... tied to post-closing sales of Ibis systems, including instruments and ...
... VILLAGE, Calif., Jan. 6 Specialists On Call, ... the states in which it provides service, including ... provider of emergency neurology on-call services to hospitals, ... consultations to date.(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/LAW515LOGO )Dr. Joe ...
... Specialists On Call, Inc. (SOC) announced ... business development staff to address the accelerating demand ... largest provider of emergency neurology on-call services to ... neurology consultations to date.(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/LAW515LOGO )Dr. ...
Cached Medicine News:Health News:American Asthma Foundation Announces Breakthrough Discovery 2Health News:American Asthma Foundation Announces Breakthrough Discovery 3Health News:SpectraScience Awarded U.S. Patent 7,469,160 for Its Unique Methods and Apparatus for Evaluating Image Focus 2Health News:SpectraScience Awarded U.S. Patent 7,469,160 for Its Unique Methods and Apparatus for Evaluating Image Focus 3Health News:Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne 2Health News:Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne 3Health News:Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne 4Health News:Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis 2Health News:Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis 3Health News:Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis 4Health News:Specialists On Call Expands Access to Emergency Neurology On-Call Services in North Carolina 2Health News:Specialists On Call Accelerating Access to Emergency Neurology On-Call Services in Florida 2
... Mouthpiece 7FT O 2 Tubing Tee Adapter, ... for fast treatment times , ... (higher percentage of respirable particles) than conventional nebulizers, ... Max 10™ disposable nebulizers deliver fast and effective ...
Nebulizer Custom Kit...
... Anesthesia and Respiratory Products, ,Westmed designs, ... for Anesthesia and Respiratory professionals. Our mission ... enhance the clinician's ability to deliver quality ... the bottom line. , ,Our web ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: